Literature DB >> 20201036

NTPDase1 governs P2X7-dependent functions in murine macrophages.

Sébastien A Lévesque1, Filip Kukulski, Keiichi Enjyoji, Simon C Robson, Jean Sévigny.   

Abstract

P2X7 receptor is an adenosine triphosphate (ATP)-gated ion channel within the multiprotein inflammasome complex. Until now, little is known about regulation of P2X7 effector functions in macrophages. In this study, we show that nucleoside triphosphate diphosphohydrolase 1 (NTPDase1)/CD39 is the dominant ectonucleotidase expressed by murine peritoneal macrophages and that it regulates P2X7-dependent responses in these cells. Macrophages isolated from NTPDase1-null mice (Entpd1(-/-)) were devoid of all ADPase and most ATPase activities when compared with WT macrophages (Entpd1(+/+)). Entpd1(-/-) macrophages exposed to millimolar concentrations of ATP were more susceptible to cell death, released more IL-1beta and IL-18 after TLR2 or TLR4 priming, and incorporated the fluorescent dye Yo-Pro-1 more efficiently (suggestive of increased pore formation) than Entpd1(+/+) cells. Consistent with these observations, NTPDase1 regulated P2X7-associated IL-1beta release after synthesis, and this process occurred independently of, and prior to, cytokine maturation by caspase-1. NTPDase1 also inhibited IL-1beta release in vivo in the air pouch inflammatory model. Exudates of LPS-injected Entpd1(-/-) mice had significantly higher IL-1beta levels when compared with Entpd1(+/+) mice. Altogether, our studies suggest that NTPDase1/CD39 plays a key role in the control of P2X7-dependent macrophage responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20201036      PMCID: PMC3045779          DOI: 10.1002/eji.200939741

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  75 in total

Review 1.  Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation.

Authors:  M J L Bours; E L R Swennen; F Di Virgilio; B N Cronstein; P C Dagnelie
Journal:  Pharmacol Ther       Date:  2006-06-19       Impact factor: 12.310

2.  Multiple P2X and P2Y receptor subtypes in mouse J774, spleen and peritoneal macrophages.

Authors:  Robson Coutinho-Silva; David M Ojcius; Darek C Górecki; Pedro M Persechini; Rodrigo C Bisaggio; Anderson N Mendes; Joanne Marks; Geoffrey Burnstock; Philip M Dunn
Journal:  Biochem Pharmacol       Date:  2005-01-12       Impact factor: 5.858

3.  CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness.

Authors:  Norikatsu Mizumoto; Tadashi Kumamoto; Simon C Robson; Jean Sévigny; Hiroyuki Matsue; Keiichi Enjyoji; Akira Takashima
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

4.  Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain.

Authors:  Hyun B Choi; Jae K Ryu; Seung U Kim; James G McLarnon
Journal:  J Neurosci       Date:  2007-05-02       Impact factor: 6.167

5.  NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse.

Authors:  Gilles Kauffenstein; Annick Drouin; Nathalie Thorin-Trescases; Hélène Bachelard; Bernard Robaye; Pedro D'Orléans-Juste; François Marceau; Eric Thorin; Jean Sévigny
Journal:  Cardiovasc Res       Date:  2010-01-01       Impact factor: 10.787

6.  Isolation and culture of murine macrophages.

Authors:  John Q Davies; Siamon Gordon
Journal:  Methods Mol Biol       Date:  2005

7.  Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine.

Authors:  Ross Corriden; Yu Chen; Yoshiaki Inoue; Guido Beldi; Simon C Robson; Paul A Insel; Wolfgang G Junger
Journal:  J Biol Chem       Date:  2008-08-18       Impact factor: 5.157

8.  Infection of human endothelium in vitro by cytomegalovirus causes enhanced expression of purinergic receptors: a potential virus escape mechanism?

Authors:  Mariët Zandberg; Willem J van Son; Martin C Harmsen; Winston W Bakker
Journal:  Transplantation       Date:  2007-11-27       Impact factor: 4.939

9.  Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.

Authors:  Guido Beldi; Yan Wu; Yara Banz; Michael Nowak; Lindsay Miller; Keiichi Enjyoji; Arvand Haschemi; Gennady G Yegutkin; Daniel Candinas; Mark Exley; Simon C Robson
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

10.  Isolation and characterization of human tonsil dendritic cells.

Authors:  D N Hart; J L McKenzie
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  49 in total

1.  Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice.

Authors:  Zachary M Huttinger; Michael W Milks; Michael S Nickoli; William L Aurand; Lawrence C Long; Debra G Wheeler; Karen M Dwyer; Anthony J F d'Apice; Simon C Robson; Peter J Cowan; Richard J Gumina
Journal:  Am J Pathol       Date:  2012-05-18       Impact factor: 4.307

Review 2.  Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.

Authors:  Karen M Dwyer; Bellamkonda K Kishore; Simon C Robson
Journal:  Nat Rev Nephrol       Date:  2020-07-08       Impact factor: 28.314

3.  P2X7 Receptor Signaling Contributes to Sepsis-Associated Brain Dysfunction.

Authors:  Luiz Eduardo Baggio Savio; Mariana G Juste Andrade; Paola de Andrade Mello; Patrícia Teixeira Santana; Aline Cristina Abreu Moreira-Souza; Janaína Kolling; Aline Longoni; Linda Feldbrügge; Yan Wu; Angela T S Wyse; Simon C Robson; Robson Coutinho-Silva
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

Review 4.  Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses.

Authors:  Fenila Jacob; Claudina Pérez Novo; Claus Bachert; Koen Van Crombruggen
Journal:  Purinergic Signal       Date:  2013-02-13       Impact factor: 3.765

5.  CD39 improves survival in microbial sepsis by attenuating systemic inflammation.

Authors:  Balázs Csóka; Zoltán H Németh; Gábor Törő; Balázs Koscsó; Endre Kókai; Simon C Robson; Keiichi Enjyoji; Rolando H Rolandelli; Katalin Erdélyi; Pál Pacher; György Haskó
Journal:  FASEB J       Date:  2014-10-15       Impact factor: 5.191

Review 6.  Adenosine metabolism, immunity and joint health.

Authors:  György Haskó; Luca Antonioli; Bruce N Cronstein
Journal:  Biochem Pharmacol       Date:  2018-02-07       Impact factor: 5.858

7.  Methionine and methionine sulfoxide treatment induces M1/classical macrophage polarization and modulates oxidative stress and purinergic signaling parameters.

Authors:  Lien M Dos Santos; Tatiane M da Silva; Juliana H Azambuja; Priscila T Ramos; Pathise S Oliveira; Elita F da Silveira; Nathalia S Pedra; Kennia Galdino; Carlus A T do Couto; Mayara S P Soares; Rejane G Tavares; Roselia M Spanevello; Francieli M Stefanello; Elizandra Braganhol
Journal:  Mol Cell Biochem       Date:  2016-10-17       Impact factor: 3.396

8.  The ecto-ATPDase CD39 is involved in the acquisition of the immunoregulatory phenotype by M-CSF-macrophages and ovarian cancer tumor-associated macrophages: Regulatory role of IL-27.

Authors:  Sènan M d'Almeida; Gilles Kauffenstein; Charlotte Roy; Laetitia Basset; Loukas Papargyris; Daniel Henrion; Véronique Catros; Norbert Ifrah; Philippe Descamps; Anne Croue; Pascale Jeannin; Marc Grégoire; Yves Delneste; Julie Tabiasco
Journal:  Oncoimmunology       Date:  2016-04-28       Impact factor: 8.110

Review 9.  Regulation of allergic inflammation by the ectoenzyme E-NPP3 (CD203c) on basophils and mast cells.

Authors:  Shih Han Tsai; Kiyoshi Takeda
Journal:  Semin Immunopathol       Date:  2016-04-30       Impact factor: 9.623

10.  CD39 modulates hematopoietic stem cell recruitment and promotes liver regeneration in mice and humans after partial hepatectomy.

Authors:  Jan Schulte Am Esch; Simon C Robson; Moritz Schmelzle; Constanze Duhme; Wolfgang Junger; Steven D Salhanick; Yu Chen; Yan Wu; Vasilis Toxavidis; Eva Csizmadia; Lihui Han; Shu Bian; Günter Fürst; Martina Nowak; Seth J Karp; Wolfram T Knoefel
Journal:  Ann Surg       Date:  2013-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.